Detalles de la búsqueda
1.
Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study.
Lancet Oncol
; 25(4): 518-528, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38547895
2.
Durable response of lung carcinoma patients to EGFR tyrosine kinase inhibitors is determined by germline polymorphisms in some immune-related genes.
Mol Cancer
; 22(1): 120, 2023 07 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37516818
3.
Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade.
Br J Cancer
; 126(4): 569-575, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34621044
4.
Exposure-response analysis of Raltitrexed assessing liver toxicity.
Br J Clin Pharmacol
; 87(3): 1327-1337, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32789966
5.
Real-world safety and effectiveness of regorafenib in metastatic colorectal cancer: the French CORRELATE cohort.
Future Oncol
; 17(25): 3343-3353, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34011165
6.
Feasibility of health-related quality of life (HRQoL) assessment for cancer patients using electronic patient-reported outcome (ePRO) in daily clinical practice.
Qual Life Res
; 30(11): 3255-3266, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33387291
7.
Molecular description of ANGPT2 associated colorectal carcinoma.
Int J Cancer
; 147(7): 2007-2018, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32222972
8.
Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trial.
BMC Cancer
; 20(1): 352, 2020 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-32334548
9.
Anti-Telomerase CD4+ Th1 Immunity and Monocytic-Myeloid-Derived-Suppressor Cells Are Associated with Long-Term Efficacy Achieved by Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) in Advanced Anal Squamous Cell Carcinoma: Translational Study of Epitopes-HPV01 and 02 Trials.
Int J Mol Sci
; 21(18)2020 Sep 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-32957741
10.
Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study.
Lancet Oncol
; 19(8): 1094-1106, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30042063
11.
Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study).
BMC Cancer
; 17(1): 574, 2017 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-28841909
12.
Prognostic value of baseline seric Syndecan-1 in initially unresectable metastatic colorectal cancer patients: a simple biological score.
Int J Cancer
; 139(10): 2325-35, 2016 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27472156
13.
Additive value of pre-operative and one-month post-operative lymphocyte count for death-risk stratification in patients with resectable pancreatic cancer: a multicentric study.
BMC Cancer
; 16(1): 823, 2016 10 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-27782813
14.
Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy.
BMC Gastroenterol
; 14: 143, 2014 Aug 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-25117717
15.
A multicenter study evaluating efficacy of immune checkpoint inhibitors in advanced non-colorectal digestive cancers with microsatellite instability.
Eur J Cancer
; 202: 114033, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38537314
16.
Metronomic cyclophosphamide: an alternative treatment for hepatic epithelioid hemangioendothelioma.
J Hepatol
; 58(6): 1254-7, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23402747
17.
Bifractionated CPT-11 with LV5FU2 infusion (FOLFIRI-3) in combination with bevacizumab: clinical outcomes in first-line metastatic colorectal cancers according to plasma angiopoietin-2 levels.
BMC Cancer
; 13: 611, 2013 Dec 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-24373251
18.
DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: a multicenter propensity score-matching study.
Exp Hematol Oncol
; 12(1): 63, 2023 Jul 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37480095
19.
Modified DCF (Docetaxel, Cisplatin and 5-fluorouracil) chemotherapy is effective for the treatment of advanced rectal squamous cell carcinoma.
Front Oncol
; 12: 974108, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36465395
20.
Long-Term Disease Control After locoregional Pelvic Chemoradiation in Patients with Advanced Anal Squamous Cell Carcinoma.
Front Oncol
; 12: 918271, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35936677